{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:26:46Z","timestamp":1793053606383,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T00:00:00Z","timestamp":1381968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"NC3Rs","award":["G0ss900775"],"award-info":[{"award-number":["G0ss900775"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.nbd.2013.10.017","type":"journal-article","created":{"date-parts":[[2013,10,19]],"date-time":"2013-10-19T15:31:17Z","timestamp":1382196677000},"page":"296-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid"],"prefix":"10.1016","volume":"62","author":[{"given":"Pishan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin S.B.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.10.017_bb0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0010","first-page":"cm2","article-title":"PI3K class IB pathway","volume":"2007","author":"Andrews","year":"2007","journal-title":"Sci. STKE"},{"key":"10.1016\/j.nbd.2013.10.017_bb0015","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nchembio.117","article-title":"Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases","volume":"4","author":"Apsel","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nn.2462","article-title":"PIP3 controls synaptic function by maintaining AMPA receptor clustering at the postsynaptic membrane","volume":"13","author":"Arendt","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0025","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0920-1211(98)00030-8","article-title":"Effects of new valproate derivatives on epileptiform discharges induced by pentylenetetrazole or low Mg2+ in rat entorhinal cortex\u2013hippocampus slices","volume":"32","author":"Armand","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ng782","article-title":"Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease","volume":"29","author":"Backman","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2013.10.017_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0022-3565(25)32552-8","article-title":"Sodium valproate enhancement of gamma-aminobutyric acid (GABA) inhibition: electrophysiological evidence for anticonvulsant activity","volume":"217","author":"Balding","year":"1981","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2013.10.017_bb0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuroscience.2004.11.031","article-title":"Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression","volume":"131","author":"Baraban","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.10.017_bb0045","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pbb.2012.08.023","article-title":"Chronic central administration of valproic acid: increased pro-survival phospho-proteins and growth cone associated proteins with no behavioral pathology","volume":"103","author":"Bates","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.017_bb0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1128\/MCB.05372-11","article-title":"Frat is a phosphatidylinositol 3-kinase\/Akt-regulated determinant of glycogen synthase kinase 3beta subcellular localization in pluripotent cells","volume":"32","author":"Bechard","year":"2012","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0092-8674(89)90026-3","article-title":"Neural and developmental actions of lithium: a unifying hypothesis","volume":"59","author":"Berridge","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2013.10.017_bb0065","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.nbd.2013.10.017_bb0060","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.eplepsyres.2010.09.001","article-title":"Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X)","volume":"92","author":"Bialer","year":"2010","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0070","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ejcb.2006.04.013","article-title":"The neuroprotective agent, valproic acid, regulates the mitogen-activated protein kinase pathway through modulation of protein kinase A signalling in Dictyostelium discoideum","volume":"85","author":"Boeckeler","year":"2006","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.51.1.41","article-title":"Comparison of valproate and phenobarbital treatment after status epilepticus in rats","volume":"51","author":"Bolanos","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2013.10.017_bb0080","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuropharm.2006.05.021","article-title":"Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats","volume":"51","author":"Brandt","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.10.017_bb0090","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1523\/JNEUROSCI.4852-10.2011","article-title":"Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy","volume":"31","author":"Buckmaster","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0085","doi-asserted-by":"crossref","first-page":"8259","DOI":"10.1523\/JNEUROSCI.4179-08.2009","article-title":"Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy","volume":"29","author":"Buckmaster","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0095","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","article-title":"The phosphoinositide 3-kinase pathway","volume":"296","author":"Cantley","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.10.017_bb0115","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2010.11.006","article-title":"Valproate decreases frequency facilitation at mossy fiber\u2014CA3 synapses after status epilepticus","volume":"93","author":"Chang","year":"2011","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0100","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/j.1528-1167.2009.02412.x","article-title":"Inhibition of long-term potentiation by valproic acid through modulation of cyclic AMP","volume":"51","author":"Chang","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.10.017_bb0105","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1242\/dmm.008029","article-title":"The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium","volume":"5","author":"Chang","year":"2012","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.nbd.2013.10.017_bb0110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2012.11.004","article-title":"Seizure control by ketogenic diet-associated medium chain fatty acids","volume":"69","author":"Chang","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.10.017_bb0120","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.neuro.28.061604.135751","article-title":"Homeostatic control of neural activity: from phenomenology to molecular design","volume":"29","author":"Davis","year":"2006","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0125","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature05185","article-title":"Phosphoinositides in cell regulation and membrane dynamics","volume":"443","author":"Di","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2013.10.017_bb0130","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.biocel.2005.05.003","article-title":"The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2","volume":"37","author":"Dyson","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.104.009308","article-title":"Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, GSK-3\u03b2 inhibition and viral replication \u2014 a screening approach for new bipolar disorder drugs based on the valproic acid core structure","volume":"67","author":"Eickholt","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1242\/dmm.008391","article-title":"Conserved valproic acid-induced lipid droplet formation in Dictyostelium and human hepatocytes (huh7) identifies structurally active compounds","volume":"5","author":"Elphick","year":"2011","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.nbd.2013.10.017_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0005-2736(89)90529-4","article-title":"Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2)","volume":"979","author":"Gabev","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2013.10.017_bb0150","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1523\/JNEUROSCI.20-08-02904.2000","article-title":"Blockade of neuronal activity during hippocampal development produces a chronic focal epilepsy in the rat","volume":"20","author":"Galvan","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0155","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0028-3908(02)00005-9","article-title":"Neuronal hyperexcitability induced by repeated brief episodes of hypoxia in rat hippocampal slices: involvement of ionotropic glutamate receptors and L-type Ca(2+) channels","volume":"42","author":"Godukhin","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.10.017_bb0160","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0091-3057(01)00663-3","article-title":"Protective effect of trans-resveratrol against kainic acid-induced seizures and oxidative stress in rats","volume":"71","author":"Gupta","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.nbd.2013.10.017_bb0165","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1046\/j.1471-4159.1999.0731363.x","article-title":"Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat","volume":"73","author":"Haughey","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2013.10.017_bb0170","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1016\/j.bmc.2006.06.046","article-title":"Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors","volume":"14","author":"Hayakawa","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"Suppl. 5","key":"10.1016\/j.nbd.2013.10.017_bb0175","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1528-1157.1994.tb05959.x","article-title":"Strategies for the development of drugs for pharmacoresistant epilepsies","volume":"35","author":"Heinemann","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2013.10.017_bb0180","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1126\/science.2899909","article-title":"Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists","volume":"241","author":"Honore","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.10.017_bb0190","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type A (GABA(A)) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2013.10.017_bb0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1083\/jcb.201005100","article-title":"Phosphatidylserine is a critical modulator for Akt activation","volume":"192","author":"Huang","year":"2011","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0195","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/11086","article-title":"Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I","volume":"1","author":"Kanzaki","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1586\/14737175.6.3.397","article-title":"Refractory epilepsy: mechanisms and solutions","volume":"6","author":"Kwan","year":"2006","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.nbd.2013.10.017_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cnr.2004.09.013","article-title":"Valproic acid: how it works. Or not","volume":"4","author":"Lagace","year":"2005","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuropharm.2008.05.033","article-title":"Up-regulation of protein l-isoaspartyl methyltransferase expression by lithium is mediated by glycogen synthase kinase-3 inactivation and beta-catenin stabilization","volume":"55","author":"Lamarre","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2013.10.017_bb0215","doi-asserted-by":"crossref","first-page":"18543","DOI":"10.1074\/jbc.M414112200","article-title":"Insulin stimulates postsynaptic density-95 protein translation via the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway","volume":"280","author":"Lee","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2013.10.017_bb0220","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1152\/jn.2002.88.2.954","article-title":"Developmental regulation of neuronal K(Ca) channels by TGFbeta1: an essential role for PI3 kinase signaling and membrane insertion","volume":"88","author":"Lhuillier","year":"2002","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0225","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(00)01559-7","article-title":"A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency","volume":"294","author":"Li","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.10.017_bb0230","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.nbd.2013.10.017_bb0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0240","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1073\/pnas.042688899","article-title":"Nucleotides and phospholipids compete for binding to the C terminus of KATP channels","volume":"99","author":"MacGregor","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.10.017_bb0245","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0250","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1046\/j.1432-1327.1999.00919.x","article-title":"Different mechanisms of protection against apoptosis by valproate and Li+","volume":"266","author":"Mora","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.nbd.2013.10.017_bb0255","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/0024-3205(81)90659-7","article-title":"Minireview. Kainic acid as a tool for the study of temporal lobe epilepsy","volume":"29","author":"Nadler","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0260","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0265","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0006-8993(72)90268-5","article-title":"Epileptiform activity and neural plasticity in limbic structures","volume":"47","author":"Racine","year":"1972","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0270","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.10.017_bb0275","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev.biochem.66.1.511","article-title":"Clathrin-coated vesicle formation and protein sorting: an integrated process","volume":"66","author":"Schmid","year":"1997","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.nbd.2013.10.017_bb0280","first-page":"402","article-title":"Effect of valproate derivatives on human brain myo-inositol-1-phosphate (MIP) synthase activity and amphetamine-induced rearing","volume":"59","author":"Shaltiel","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.nbd.2013.10.017_bb0285","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1172\/JCI200419971","article-title":"Bim regulation may determine hippocampal vulnerability after injurious seizures and in temporal lobe epilepsy","volume":"113","author":"Shinoda","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2013.10.017_bb0290","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0955-0674(03)00074-7","article-title":"Spatial control of exocytosis","volume":"15","author":"Spiliotis","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0295","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1126\/science.277.5325.567","article-title":"Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B","volume":"277","author":"Stokoe","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.10.017_bb0300","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0301-0082(88)90027-5","article-title":"NMDA receptors and ligands in the vertebrate CNS","volume":"30","author":"Stone","year":"1988","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0006-8993(89)90268-0","article-title":"Pentylenetetrazole-induced changes of the single potassium channel in primary cultured cerebral cortical neurons","volume":"497","author":"Sugaya","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0310","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1476-5381.2009.00358.x","article-title":"Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2","volume":"158","author":"Suwa","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0315","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1042\/BST0371126","article-title":"Structure\u2013function studies for the panacea, valproic acid","volume":"37","author":"Terbach","year":"2009","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2013.10.017_bb0320","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M004179200","article-title":"Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis","volume":"276","author":"Vaden","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2013.10.017_bb0325","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrm3290","article-title":"PI3K signalling: the path to discovery and understanding","volume":"13","author":"Vanhaesebroeck","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0330","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nn1300","article-title":"PI3K promotes voltage-dependent calcium channel trafficking to the plasma membrane","volume":"7","author":"Viard","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0335","doi-asserted-by":"crossref","first-page":"825364","DOI":"10.1155\/2012\/825364","article-title":"AMPA receptor trafficking in homeostatic synaptic plasticity: functional molecules and signaling cascades","volume":"2012","author":"Wang","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.nbd.2013.10.017_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0165-6147(90)90038-A","article-title":"Structure\u2013activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists","volume":"11","author":"Watkins","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2013.10.017_bb0345","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s11064-007-9348-3","article-title":"Lithium and valproate protect hippocampal slices against ATP-induced cell death","volume":"32","author":"Wilot","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0350","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1158\/0008-5472.CAN-09-4355","article-title":"Drugging the PI3 kinome: from chemical tools to drugs in the clinic","volume":"70","author":"Workman","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.nbd.2013.10.017_bb0360","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.2174\/092986710793361234","article-title":"PI3K\/Akt\/mTOR pathway inhibitors in cancer: a perspective on clinical progress","volume":"17","author":"Wu","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.nbd.2013.10.017_bb0355","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/mol.111.072744","article-title":"Valproic acid induces monoamine oxidase A via Akt\/forkhead box O1 activation","volume":"80","author":"Wu","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0365","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/EC.00104-06","article-title":"Attenuation of phospholipid signaling provides a novel mechanism for the action of valproic acid","volume":"6","author":"Xu","year":"2007","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.nbd.2013.10.017_bb0375","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4255\/mcpharmacol.09.16","article-title":"Developing antiepileptogenic drugs for acquired epilepsy: targeting the mammalian target of rapamycin (mTOR) pathway","volume":"1","author":"Zeng","year":"2009","journal-title":"Mol. Cell. Pharmacol."},{"key":"10.1016\/j.nbd.2013.10.017_bb0370","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4161\/cc.9.12.11866","article-title":"Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword?","volume":"9","author":"Zeng","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nbd.2013.10.017_bb0380","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1528-1167.2011.03384.x","article-title":"Pentylenetetrazole-induced seizures cause acute, but not chronic, mTOR pathway activation in rat","volume":"53","author":"Zhang","year":"2012","journal-title":"Epilepsia"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113002921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T17:39:17Z","timestamp":1746034757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113002921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":76,"alternative-id":["S0969996113002921"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.10.017","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2013.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}